Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 54: 606-610, 2008; 10.1373/clinchem.2007.097139
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rahalkar, A. R.
Right arrow Articles by Mattman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rahalkar, A. R.
Right arrow Articles by Mattman, A.
Related Collections
Right arrow Clinical Case Studies
(Clinical Chemistry. 2008;54:606-610.)
© 2008 American Association for Clinical Chemistry, Inc.


Clinical Case Study

An Unusual Case of Severe Hypertriglyceridemia and Splenomegaly

Amit R. Rahalkar1, Jian Wang1, Sandra Sirrs2, James Dimmick3, Daniel Holmes4, Nadine Urquhart4, Robert A. Hegele1,a and Andre Mattman2

1 Robarts Research Institute and Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada;2 Adult Metabolic Disease Clinic, Department of Medicine, Vancouver General Hospital, UBC, Vancouver, British Columbia, Canada;3 Department of Pathology and Laboratory Medicine, Children’s and Women’s Health Centre of British Columbia, UBC, Vancouver, British Columbia, Canada;4 Department of Pathology and Laboratory Medicine, St. Paul’s Hospital, UBC, Vancouver, British Columbia, Canada.

aAddress correspondence to this author at: Robarts Research Institute, 406-100 Perth Drive, London, Ontario, Canada N6A 5K8. Fax: +1 519 663 3037; e-mail hegele@robarts.ca.

The first 300 words of the full text of this article appear below.


CASE

A 49-year-old man of Japanese and British ancestry was referred to a metabolic diseases clinic for evaluation 5 months after nontraumatic spleen rupture requiring splenectomy. Prior history included hypertension and mild frontal headaches, but no other neurological or cardiovascular symptoms. The patient did not smoke and used alcohol infrequently. His mother had coronary artery disease, and his father had mild hypertension. There was no family history of consanguinity, splenomegaly, diabetes, or developmental delay.

The ruptured spleen weighed 727 g, and splenomegaly was associated with marked sinus histiocytosis spreading apart the lymphoid component. The overwhelming majority of histiocytes were foamy (Fig. 1a ), and only a few had sea-blue appearance and reacted positively with periodic acid-Schiff (PAS), PAS and diastase, and May-Giemsa stains. A lipid storage disorder was suspected, but the histiocytes did not have the cytoplasmic linearity appearance of Gaucher cells and were otherwise nonspecific. Before splenic rupture, the patient’s lipoprotein profile was reported as being normal, with no past recorded triglyceride measurement exceeding 2 mmol/L.


Figure Removed (Available Only in the Full Text)
View larger version (56K):



 
Figure 1. Pathology and genomic studies of the index patient.

(a), Hematoxylin and eosin–stained section (40x) of spleen, showing expanded white pulp displacing Malpighian bodies. The pallor is due to the abundance of foamy histiocytes in the sinusoids, seen in inset (400X). (b), LightCycler (Roche Diagnostics) analysis of genomic DNA with curve C representing the patient’s APOE melting curve at codon 158, showing heterozygosity at codon 158 for 1 TGC trinucleotide (cysteine) with Tm of 56.4 °C and 1 indeterminate trinucleotide coding sequence with a melting temperature of 62.99 °C, which was outside the Cys158 acceptable range of 63.5–68.5 °C, indicating another amino acid encoded by this residue. Melting curves for normal E2/E4 (A) and E2/E3 (B) controls are shown for reference. (c), Direct sequencing of the patient’s plasmid cloned APOE alleles showing inframe . . . [Full Text of this Article]


DISCUSSION


Points to remember







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Association for Clinical Chemistry.